Novel glycosylated endomorphin-2 analog produces potent centrally-mediated antinociception in mice after peripheral administration

Fichna, Jakub and Mazur, Marzena and Grzywacz, Daria and Kamysz, Wojciech and Perlikowska, Renata and Tóth, Géza (2013) Novel glycosylated endomorphin-2 analog produces potent centrally-mediated antinociception in mice after peripheral administration. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 23 (24). pp. 6673-6676. ISSN 0960-894X

Text FichnaBioorgMedCL.pdf Restricted to Repository staff only Download (539kB) | Request a copy

Abstract

We report the synthesis and pharmacological characterization of a novel glycosylated analog of a potent and selective endogenous mu-opioid receptor (MOP) agonist, endomorphin-2 (Tyr-Pro-Phe-Phe-NH2, EM2), obtained by the introduction in position 3 of the tyrosine residue possessing the glucose moiety attached to the phenolic function via a beta-glycosidic bond. The improved blood-brain barrier permeability and enhanced antinociceptive effect of the novel glycosylated analog suggest that it may be a promising template for design of potent analgesics. Furthermore, the described methodology may be useful for increasing the bioavailability and delivery of opioid peptides to the CNS. (C) 2013 Elsevier Ltd. All rights reserved.

Actions (login required)

Edit Item